Liechtenstein vs Serbia: Breast cancer screening coverage in Europe
Liechtenstein
11.9%
in 2022
Serbia
6.1%
in 2022
Liechtenstein rank
25th
Serbia rank
26th
Breast cancer screening coverage in Europe over time
- Liechtenstein
- Serbia
How they compare
Liechtenstein currently reports 11.9% against 6.1% in Serbia, a difference of 5.8%.
That makes Liechtenstein's figure about 2.0 times Serbia's.
The two have swapped places 1 time across 9 shared years of data; in 2014 it was Serbia ahead.
Liechtenstein ranks 25th and Serbia ranks 26th of 26 countries.
Across the 2 decades both report, Liechtenstein averaged higher in 1 and Serbia in 1.
Head to head by decade
| Decade | Liechtenstein | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7.6% | 9.7% | 2.1% | Serbia |
| 2020s | 10.1% | 6.3% | 3.8% | Liechtenstein |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher breast cancer screening coverage in europe, Liechtenstein or Serbia?
- Liechtenstein, at 11.9% against 6.1% in Serbia as of 2022.
- What is the difference in breast cancer screening coverage in europe between Liechtenstein and Serbia?
- 5.8%, with Liechtenstein ahead.
- How many years of comparable data are there for Liechtenstein and Serbia?
- 9 years are reported by both, from 2014 to 2022.
- How do Liechtenstein and Serbia rank globally for breast cancer screening coverage in europe?
- Liechtenstein ranks 25th and Serbia ranks 26th of 26 countries.
- Where does this data come from?
- Eurostat (2024) – processed by Our World in Data, published as Breast cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of women aged 50 to 69 years who have been screened for breast cancer within the previous 2 years.